Home › Hartfalen › Arizona › Phoenix
Hartfalen klinische studies in Phoenix, AZ
18 studies voor Hartfalen zoeken deelnemers op locaties in en rond Phoenix (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
ELEVATE-HFpEF Clinical Study
Rekruteren
- Banner - University Medical Center Phoenix, Phoenix
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RekruterenFase 3
- Research Site, Phoenix
- Research Site, Phoenix
BiVACOR® Total Artificial Heart Early Feasibility Study
Rekruteren
- Banner - University Medical Center Phoenix, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruterenFase 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekruterenFase 3
- Phoenix, AZ Investigative Site CON-10115, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruterenFase 3
- Phoenix, AZ Investigative Site 10115, Phoenix
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Rekruteren
- Mayo Clinic Phoenix, Phoenix
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Rekruteren
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruterenFase 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Assessment of CCM in HF With Higher Ejection Fraction
Rekruteren
- Arizona Heart Rhythm, Phoenix
- Cardiovascular Consultants, Ltd, Phoenix
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RekruterenFase 3
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekruteren
- St. Joseph's Hospital and Medical Center, Phoenix
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekruteren
- Banner-University Medical Center Phoenix, Phoenix
CCM OPEN HF Registry
RekruterenObservatieonderzoek
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekruteren
- Banner Health - Phoenix, Phoenix
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Rekruteren
- Arizona Heart Foundation, Phoenix
His-Bundle Corrective Pacing in Heart Failure
Rekruteren
- University of Arizona, Phoenix
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
RekruterenGezonde vrijwilligers welkom
- Multiple Locations, Phoenix
Hartfalen studies in andere steden
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Andere studies in Phoenix
- Borstkanker25 studies
- Colorectale kanker25 studies
- Obesitas22 studies
- Niet-kleincellige longkanker20 studies
- Metastatische kanker20 studies
- Prostaatkanker17 studies
- Kanker (alle vormen)17 studies
- Multipel myeloom16 studies
- Aldermeesklierkanker16 studies
- Cardiovasculaire ziekte16 studies
- Ziekte van Alzheimer15 studies
- Overgewicht15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.